Search

Papageorgiou, Georgios, David Symeonidis, Sergios Tsakatikas, Alexandros Liatsos, Konstantinos Aa Douglas, Vivian Douglas, Marilita Moschos, and Christos Kosmas. 2021. “Central Neurotoxicity Induced by Trastuzumab Emtansine (T-DM1): A Case Report”. Anticancer Drugs 32 (10): 1146-49.

Bresler, Scott, Caroline Simon, Carol Shields, Jonathan McHugh, Anna Stagner, and Rajiv Patel. 2022. “Conjunctival Melanocytic Lesions”. Arch Pathol Lab Med 146 (5): 632-46.

Rosenblatt, Tatiana, Daniel Vail, Cassie Ludwig, Ahmad Al-Moujahed, Malini Veerappan Pasricha, Marco Ji, Natalia Callaway, and Darius Moshfeghi. 2023. “Fall Risk in Patients With Pseudophakic Monovision”. Can J Ophthalmol 58 (1): 11-17.

Konstantinou, Eleni, Noreen Shaikh, and David Ramsey. 2021. “Birt-Hogg-Dubé Syndrome Associated With Chorioretinopathy and Nyctalopia: A Case Report and Review of the Literature”. Ophthalmic Genet, 1-7.

Greiner, Jack. 2016. “Long-Term (3 Year) Effects of a Single Thermal Pulsation System Treatment on Meibomian Gland Function and Dry Eye Symptoms.”. Eye Contact Lens 42 (2): 99-107.

Solyman, Omar, Mohamed Zaakouk, and Abdelrahman Elhusseiny. 2021. “Juvenile Ossifying Fibroma of the Maxilla Presenting With Proptosis and Dystopia in a 4-Year-Old Child”. Orbit 40 (4): 347-49.

Elhusseiny, Abdelrahman, Taher Eleiwa, Magdi Yacoub, Joseph George, Reem ElSheikh, Abid Haseeb, James Kwan, et al. 2021. “Relationship Between Screen Time and Dry Eye Symptoms in Pediatric Population During the COVID-19 Pandemic”. Ocul Surf 22: 117-19.

Zhang, Mingui, Tao Chen, and Yisheng Zhong. 2021. “Demographic and Prognostic Factors of Optic Nerve Astrocytoma: A Retrospective Study of Surveillance, Epidemiology, and End Results (SEER)”. BMC Cancer 21 (1): 976.

Ung, Lawson, and James Chodosh. 2021. “Urgent Unmet Needs in the Care of Bacterial Keratitis: An Evidence-Based Synthesis”. Ocul Surf.

Ruan, Yue, Subao Jiang, Aytan Musayeva, Norbert Pfeiffer, and Adrian Gericke. 2021. “Corneal Epithelial Stem Cells-Physiology, Pathophysiology and Therapeutic Options”. Cells 10 (9).